Cite
MLA Citation
W.C. Ports et al.. “A randomized phase 2a efficacy and safety trial of the topical Janus kinase inhibitor tofacitinib in the treatment of chronic plaque psoriasis.” British journal of dermatology, vol. 169, n.d., pp. 137–145. http://access.bl.uk/ark:/81055/vdc_100024478765.0x00004b